The current status of immunobased therapies for metastatic renal-cell carcinoma
Niranjan J Sathianathen,1 Suprita Krishna,1 J Kyle Anderson,1,2 Christopher J Weight,1,2 Shilpa Gupta,2,3 Badrinath R Konety,1,2 Thomas S Griffith1,2,4,5 1Department of Urology, 2Masonic Cancer Center, 3Division of Hematology, Oncology, and Transplantation, 4Center for Immunology, 5Microbiology, Imm...
Main Authors: | Sathianathen NJ, Krishna S, Anderson JK, Weight CJ, Gupta S, Konety BR, Griffith TS |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2017-12-01
|
Series: | ImmunoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/the-current-status-of-immunobased-therapies-for-metastatic-renal-cell--peer-reviewed-article-ITT |
Similar Items
-
Utilization and perioperative complications of laparoscopic cryoablation vs. robotic partial nephrectomy for localized renal tumors
by: Aaron C. Weinberg, et al.
Published: (2015-06-01) -
Novel immunotherapy in metastatic renal cell carcinoma
by: Yang Hyun Cho, et al.
Published: (2017-07-01) -
Clinical Analysis of Interventional Bronchoscopy
for the Treatment of Malignant Obstructive Atelectasis
by: Hongwu WANG, et al.
Published: (2011-08-01) -
Progress in Immunotherapy for Non-small Cell Lung Cancer
by: Yan XU, et al.
Published: (2014-01-01) -
Progress in Immunotherapy for Squamous Non-small Cell Lung Cancer
by: Shouzheng WANG, et al.
Published: (2016-10-01)